Ongoing
CTN 336: Québec HIV Cohort
A learning health system to improve care in people living with HIV
Learn MoreOngoing
A learning health system to improve care in people living with HIV
Learn MoreEnrolling
The role of female sex hormones and chronic/latent co-infections on cellular aging and comorbidities in women living with HIV
Learn MoreReporting
Immunogenicity outcomes in people living with HIV following vaccination for COVID-19 (HIV-COV)
Learn MoreEnrolling
Ongoing
HIV Prevention for Gay, Bisexual, and other Men Who Have Sex with Men
Learn MoreReporting
Ongoing
Effectiveness of early treatment with anti-retroviral therapy in children with HIV
Learn MoreCompleted
Enrolling
Discovering pathways to successful aging in people living with HIV
Learn MoreCTN Trials have been approved by the Community Advisory Committee of the Canadian HIV Trials Network and the Network’s Scientific Review Committee, or other national peer-review panels such as those at the Canadian Institutes of Health Research and the U.S. National Institutes of Health. CTNPT studies are small-scale investigations designed to determine the feasibility of research concepts, and do not all go through the regular CTN clinical trial review process. For information on the benefits and risks of participating in HIV clinical trials, call CATIE toll-free at 1-800-263-1638.